Fujita, Atsuhiro
Fujita, Yuko
Pu, Yaoyu
Chang, Lijia
Hashimoto, Kenji http://orcid.org/0000-0002-8892-0439
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18dm0107119)
Article History
Received: 11 February 2019
Accepted: 9 August 2019
First Online: 15 August 2019
Compliance with ethical standards
:
: Dr. Hashimoto is an inventor on a filed patent application on “The use of (<i>R</i>)-ketamine in the treatment of psychiatric diseases,” “(<i>S</i>)-norketamine and salt thereof as pharmaceutical,” and “The use of (<i>R</i>)-ketamine in the treatment of neurodegenerative diseases” by Chiba University. Dr. Hashimoto has received research support from Dainippon-Sumitomo, Otsuka, and Taisho. Other authors declare no conflict of interest.